Barcelona-based GP Inveready has held a €55m first close for its maiden private equity fund, Gaea Inversion, which launched in September 2019 with a €110m target.
US conglomerate J.M. Huber has agreed to buy the Italian specialty fertilizers producer
Deal is first full exit from specialist healthcare investor's maiden mid-market fund
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe